Skip to content

Clinical trials

Phase 1/2 Staphylococcal Infections trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Staphylococcal Infections Phase: Phase 1/2 Country / region: United States Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20121
20151
20171
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Aridis Pharmaceuticals, Inc.1
Armata Pharmaceuticals, Inc.1
AstraZeneca1
Henry M. Jackson Foundation for the Advancement of Military Medicine1
National Institute of Allergy and Infectious Diseases (NIAID)1
XBiotech, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Staphylococcal Infections6
Bacteremia2
Dermatitis, Atopic1
Kidney Failure, Chronic1
Pneumonia1
Sepsis1
Soft Tissue Infections1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.